Endoscopic endonasal resection of advanced stage T3/T4 sinonasal malignancies involving the skull base: monocentric single-surgeon study (2020-2024)

Authors

  • T. Popov Department of ENT Diseases, Faculty of Medicine, Medical University – Sofia, Bulgaria Author https://orcid.org/0000-0002-8205-3573
  • S. Dimitrov Department of ENT Diseases, Faculty of Medicine, Medical University – Sofia, Bulgaria Author
  • V. Dobriyanova Department of ENT Diseases, Faculty of Medicine, Medical University – Sofia, Bulgaria Author
  • S. Valcheva Department of ENT Diseases, Faculty of Medicine, Medical University – Sofia, Bulgaria Author
  • L. Dimitrov Department of ENT Diseases, Faculty of Medicine, Medical University – Sofia, Bulgaria Author
  • V. Marinov Department of ENT Diseases, Faculty of Medicine, Medical University – Sofia, Bulgaria Author
  • Tz. Marinov Department of Anesthesiology and Intensive care, Faculty of Medicine, Medical University – Sofia, Bulgaria Author
  • A. Schreiber Unit of Otorhinolayngology, Manerbio and Desenzano Hospitals, ASST del Garda, Brescia, Italy Author
  • S. Skelina Department of Neurology, Faculty of Medicine, Medical University – Sofia, Bulgaria Author

DOI:

https://doi.org/10.2478/AMB-2025-0071

Keywords:

skull base endoscopic surgery, squamous cell carcinoma, internal carotid artery, dura mater, recurrence-free survival

Abstract

Objective: This study aims to evaluate the outcomes of endoscopic endonasal resection in patients with advanced-stage T3/T4 sinonasal malignancies involving the skull base, analyzing surgical efficacy, challenges, and implications for future clinical practice. Materials and Methods: A retrospective analysis was conducted on a monocentric single-surgeon cohort of 16 patients (mean age 60.7 ± 10.5 years) diagnosed with T3/T4 sinonasal malignancies affecting subsites of the skull-base region between 2020 and 2024. All the patients underwent primary radical endoscopic endonasal resection at the Department of ENT, Head & Neck Surgery, University Hospital “Tsaritsa Ioanna – ISUL”, Medical University – Sofia, followed by adjuvant radiotherapy. Results: The cohort consisted of predominantly male patients (56.25%), with squamous cell carcinoma being the most common histological type (81.25%). Outcomes indicated a recurrence-free survival rate of 81.3% at a median follow-up of 30 months. Intraoperative findings revealed complexities in distinguishable tumor invasion, especially concerning critical anatomical structures, necessitating meticulous surgical techniques. Conclusions: Endoscopic endonasal resection demonstrates potential efficacy in managing advanced sinonasal malignancies, with a favorable recurrence-free survival rate underscoring its role as a viable surgical option. The study emphasizes the importance of individualized treatment strategies and the need for multidisciplinary collaboration to optimize patient care in this challenging clinical scenario.

References

Abdou R, Baredes S. Population-Based Results in the Management of Sinonasal and Ventral Skull Base Malignancies. Otolaryngol Clin North Am, 2017, 50(2):481-97.

Sharma RK, Irace AL, Schlosser RJ, et al. Conditional and Overall Disease-Specific Survival in Patients With Paranasal Sinus and Nasal Cavity Cancer: Improved Outcomes in the Endoscopic Era. Am J Rhinol Allergy. 2022; 36(1):57-64.

Patel CR, Fernandez-Miranda JC, Wang WH, et al. Skull Base Anatomy. Otolaryngol Clin North Am, 2016, 49(1):9-20.

Gerlach R, Modesti CL, Rampinelli V. Interdisciplinary Management of Skull Base Tumors. Laryngorhinootologie, 2024,103(S 01):S28-S42.

AlQahtani A, London NR Jr, Castelnuovo P, et al. Assessment of Factors Associated With Internal Carotid Injury in Expanded Endoscopic Endonasal Skull Base Surgery. JAMA Otolaryngol Head Neck Surg, 2020, 146(4):364-372.

Rawal RB, Farzal Z, Federspiel JJ, et al. Endoscopic Resection of Sinonasal Malignancy: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg, 2016, 155(3):376-86.

Filtenborg MV, Lilja-Fischer JK, Sharma MB, et al. Sinonasal cancer in Denmark 2008-2015: a population-based phase-4 cohort study from DAHANCA. Acta Oncol, 2021, 60(3):333-342.

Ferrari M, Mattavelli D, Tomasoni M, et al. The MUSES: a prognostic study on 1360 patients with sinonasal cancer undergoing endoscopic surgery-based treatment: Multi-institutional collaborative Study on Endoscopically treated Sinonasal cancers. Eur J Cancer, 2022, 171:161-182.

Bechev K, Yotova NI, Kostadinov K, et al. Anatomical Features and Morphometric Characteristics of the Sphenoidal Sinus in MRI Studies. Cureus. 2024, 16(8):e66764.

Abdelmeguid AS, Bell D, Hanna EY. Sinonasal Undifferentiated Carcinoma. Curr Oncol Rep, 2019, 21(3):26.

Bechev K, Stoitsev T, Markov D, et al. Osteoma of the Posterior Wall of the Sphenoid Sinus in a 29-Year-Old Woman – A Case Report. Acta Medica Bulgarica, 2025, 52(2):78-82.

Downloads

Published

10.12.2025

Issue

Section

ORIGINAL ARTICLES

How to Cite

Popov, T., Dimitrov, S., Dobriyanova, V., Valcheva, S., Dimitrov, L., Marinov, V., Marinov, T., Schreiber, A., & Skelina, S. (2025). Endoscopic endonasal resection of advanced stage T3/T4 sinonasal malignancies involving the skull base: monocentric single-surgeon study (2020-2024). Acta Medica Bulgarica, 52(4), 18-23. https://doi.org/10.2478/AMB-2025-0071